NeuroBo Pharmaceuticals Inc (NRBO)
3.06
-0.04
(-1.29%)
USD |
NASDAQ |
Apr 25, 16:00
3.14
+0.08
(+2.61%)
After-Hours: 20:00
NeuroBo Pharmaceuticals Total Assets (Quarterly): 22.78M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.78M |
| September 30, 2023 | 26.42M |
| June 30, 2023 | 29.18M |
| March 31, 2023 | 31.49M |
| December 31, 2022 | 33.53M |
| September 30, 2022 | 7.557M |
| June 30, 2022 | 10.08M |
| March 31, 2022 | 13.46M |
| December 31, 2021 | 16.80M |
| September 30, 2021 | 8.077M |
| June 30, 2021 | 10.72M |
| March 31, 2021 | 14.16M |
| December 31, 2020 | 10.97M |
| September 30, 2020 | 13.20M |
| June 30, 2020 | 15.55M |
| March 31, 2020 | 11.54M |
| December 31, 2019 | 14.47M |
| Date | Value |
|---|---|
| September 30, 2019 | 2.048M |
| June 30, 2019 | 4.014M |
| March 31, 2019 | 6.158M |
| December 31, 2018 | 3.82M |
| September 30, 2018 | 24.87M |
| June 30, 2018 | 28.81M |
| March 31, 2018 | 34.84M |
| December 31, 2017 | 19.02M |
| September 30, 2017 | 26.21M |
| June 30, 2017 | 23.00M |
| March 31, 2017 | 29.84M |
| December 31, 2016 | 24.75M |
| September 30, 2016 | 28.92M |
| June 30, 2016 | 6.726M |
| March 31, 2016 | 1.658M |
| December 31, 2015 | 4.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.048M
Minimum
Sep 2019
33.53M
Maximum
Dec 2022
15.58M
Average
13.46M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Conmed Corp | 2.300B |
| Eli Lilly and Co | 64.01B |
| Vanda Pharmaceuticals Inc | 648.44M |
| Alaunos Therapeutics Inc | 8.263M |
| Relmada Therapeutics Inc | 97.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.096M |
| Shareholders Equity (Quarterly) | 16.68M |